Fort Sheridan Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Fort Sheridan Advisors's AMGN Position: Q2 2026 in Review
Fort Sheridan Advisors increased its Amgen (AMGN) stake by 0.85% in Q2 2026, buying an estimated $24.6K and bringing the position to 8,505 shares worth $3.08M. The position accounts for 0.33% of the portfolio, ranked #61.
Fort Sheridan Advisors first reported a position in AMGN in Q3 2019 and has held it in 28 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Fort Sheridan Advisors held 8,505 shares of Amgen worth $3.08M as of Q2 2026.
- Fort Sheridan Advisors bought 72 Amgen shares in Q2 2026, an estimated $24.6K.
- Amgen made up 0.33% of Fort Sheridan Advisors's portfolio in Q2 2026, its #61 holding.
- Fort Sheridan Advisors first reported a position in Amgen in Q3 2019 and has held it in 28 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.